Box 19

Scope and Contents: A division of Olin Mathieson Chemical Corporation · Two License Agreements. · Legal agreement regarding the production of antibiotics. · Scientific results of testing with Neomycin. · Copies of the Squibb patent. · Heated correspondence over royalties withheld for sales in...

Scope and Contents:

· Tested the Roussel Corporation/UCLAF product Framycetin. During testing Framycetin seemed to be identical to Neomycin B. Business and Scientific Correspondence.

Scope and Contents: Correspondence grouped by company then chronologically. · Nopco Chemical Company · Publicker Industries, Inc. · Julius Schmid, Inc. · Smith, Kline and French Laboratories · Warner-Lambert Pharmaceutical Company · Wyeth Laboratories,...

Scope and Contents:

Original document order kept.

· E.R. Squibb

o Squibb patent for the addition-extraction process.

o Royalty and legal correspondence.

o Correspondence leading to and during arbitration.

· Query from Laboratorios Bagó.

· Query to Lepetit if they are producing Streptomycin in Argentina.

Scope and Contents:

· Title of main document: "In the matter of the informal arbitration of a claim by Rutgers Research and Educational Foundation against Olin Mathieson Chemical Corporation for royalties on sales of Streptomycin and Dihydrostreptomycin made or sold in Argentina subsequent to January 1, 1960" (September 2, 1965)

· Other legal memos and legal opinions all dealing with Squibb.

Scope and Contents:

· Instituto Terapeutico Pan-Organico Sociedade Anonima

· Industria Brasileira de Procutos Quimica Ltda.

o Legal involvement to patent new process.

· Squibb tried to register/trade mark the name "Neomicina" in Brazil and it was overruled. Schering was successful in registering the name, but the allowance was appealed.

Scope and Contents:

Grouped by country, then company and finally chronologically.

Scope and Contents: Original document order kept. · H. Lundbeck and Company o License Agreement o Business/personal correspondence with Dr. O. Hübner and Dr. S. Waksman; the two seemed to have a very good relationship and visited with each other often. o Hübner expressed concern over SIFA, Heyden, Takeda and Leo encroaching on the patents rightfully held by Wasksman. Hübner was current on all the Streptomycin/Neomycin European and Asian...

Scope and Contents:

Grouped by country, then company and finally chronologically.

· Most correspondence focuses on companies attempting to trademark the name "Neomicina". More extensive coverage of this issue with the Brazilian papers in folder number 6 (Brazil—Licensees—Foreign).

Scope and Contents: Original document order kept, grouped by company. · Roussel Corporation/UCLAF o French correspondence with translations provided. o Framycetin/Neomycin similarities debated. o Copy of the "Separation of Neomycins" patent by Roussel-UCLAF · SIFA o French correspondence, not all translated. o Letters regarding owed royalities. ...